Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist

The prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute n...

Full description

Bibliographic Details
Main Authors: Elena V. Reznik, Semen Yu. Soltis, Dmitrii V. Ustiuzhanin, Igor G. Nikitin
Format: Article
Language:English
Published: Concilium Medicum 2019-09-01
Series:КардиоСоматика
Subjects:
Online Access:https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdf
id doaj-2ce04587d1f44d1a9421f062fafb651c
record_format Article
spelling doaj-2ce04587d1f44d1a9421f062fafb651c2021-04-02T20:59:44ZengConcilium MedicumКардиоСоматика2221-71852658-57072019-09-01103132910.26442/22217185.2019.3.19057241560Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologistElena V. Reznik0Semen Yu. Soltis1Dmitrii V. Ustiuzhanin2Igor G. Nikitin3Pirogov Russian National Research Medical UniversityPirogov Russian National Research Medical UniversityNational Medical Research Center of CardiologyPirogov Russian National Research Medical UniversityThe prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute number of the patients in whom there is a lack of efficacy of optimally prescribed drug therapy. These patients are considering initiating cardiac resynchronization therapy (CRT). CRT is recommended for the patients with chronic heart failure II-IV functional class with severe left ventricular systolic dysfunction and prolonged QRS complex. Despite careful selection of patients for CRT implantation, the device does not lead to the expected result in one third of cases. To increase the effectiveness of this intervention, the procedure should be performed in accordance with current guidelines only for compliant patients who have been at least 3 months on selected optimal drug therapy, should use the optimal strategies and modes of stimulation and the adequate drug support after the intervention. The number of patients with long-term use of CRT is constantly growing. More and more patients with installed devices come into the field of vision of general practitioners and cardiologists of ambulatory clinics and hospitals, for whom it is extremely important to understand the specifics of the methods and tactics of managing such patients. This publication is dedicated to this.https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdfchronic heart failurecardiac resynchronization therapyimplantable cardioverter-defibrillatoroptimal drug therapyprognosisquality of lifeleft ventricular ejection fraction
collection DOAJ
language English
format Article
sources DOAJ
author Elena V. Reznik
Semen Yu. Soltis
Dmitrii V. Ustiuzhanin
Igor G. Nikitin
spellingShingle Elena V. Reznik
Semen Yu. Soltis
Dmitrii V. Ustiuzhanin
Igor G. Nikitin
Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
КардиоСоматика
chronic heart failure
cardiac resynchronization therapy
implantable cardioverter-defibrillator
optimal drug therapy
prognosis
quality of life
left ventricular ejection fraction
author_facet Elena V. Reznik
Semen Yu. Soltis
Dmitrii V. Ustiuzhanin
Igor G. Nikitin
author_sort Elena V. Reznik
title Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
title_short Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
title_full Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
title_fullStr Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
title_full_unstemmed Cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
title_sort cardiac resynchronization therapy in patients with chronic heart failure: the view of a therapist, cardiologist
publisher Concilium Medicum
series КардиоСоматика
issn 2221-7185
2658-5707
publishDate 2019-09-01
description The prevalence of the chronic heart failure is increasing due to the success of cardiology and the increase in life expectancy of the population. A greater number of patients live up to the clinically pronounced stages of the chronic heart failure. This issue leads to an increasing in the absolute number of the patients in whom there is a lack of efficacy of optimally prescribed drug therapy. These patients are considering initiating cardiac resynchronization therapy (CRT). CRT is recommended for the patients with chronic heart failure II-IV functional class with severe left ventricular systolic dysfunction and prolonged QRS complex. Despite careful selection of patients for CRT implantation, the device does not lead to the expected result in one third of cases. To increase the effectiveness of this intervention, the procedure should be performed in accordance with current guidelines only for compliant patients who have been at least 3 months on selected optimal drug therapy, should use the optimal strategies and modes of stimulation and the adequate drug support after the intervention. The number of patients with long-term use of CRT is constantly growing. More and more patients with installed devices come into the field of vision of general practitioners and cardiologists of ambulatory clinics and hospitals, for whom it is extremely important to understand the specifics of the methods and tactics of managing such patients. This publication is dedicated to this.
topic chronic heart failure
cardiac resynchronization therapy
implantable cardioverter-defibrillator
optimal drug therapy
prognosis
quality of life
left ventricular ejection fraction
url https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45923/pdf
work_keys_str_mv AT elenavreznik cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist
AT semenyusoltis cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist
AT dmitriivustiuzhanin cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist
AT igorgnikitin cardiacresynchronizationtherapyinpatientswithchronicheartfailuretheviewofatherapistcardiologist
_version_ 1721545832064352256